| Mr Charlton Richard Covill, RN - CRNFA | |
|
15629 E Sanoque Blvd, Chandler, AZ 85249-9421 | |
| (480) 814-7132 | |
| Not Available |
| Full Name | Mr Charlton Richard Covill |
|---|---|
| Gender | Male |
| Speciality | Clinical Nurse Specialist - Perioperative |
| Location | 15629 E Sanoque Blvd, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831177781 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP2800X | Clinical Nurse Specialist - Perioperative | RN063578 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Charlton Richard Covill, RN - CRNFA 15629 E Sanoque Blvd, Chandler, AZ 85249-9421 Ph: (480) 814-7132 | Mr Charlton Richard Covill, RN - CRNFA 15629 E Sanoque Blvd, Chandler, AZ 85249-9421 Ph: (480) 814-7132 |
News Archive
Researchers at the University Hospital of Magdeburg (Germany) have discovered that atrial tachycardia is associated with mitochondrial dysfunction and oxidative stress followed by the activation of the NF-kB signalling pathway with induction of NF-kB target gene expression in atrial tissue.
Thousands of rare diseases cumulatively affect millions of people across the globe, yet because each case is so rare doctors struggle to accurately diagnose and effectively treat individual patients. Every time a patient with an unspecified disorder walks into a new clinic or shows up in an emergency room, doctors must start from scratch. The patients often go through years of such experiences before they ever get a diagnosis.
Omeros Corporation today announced that it has submitted to the U.S. Food and Drug Administration (FDA) an investigational new drug (IND) application to initiate the Phase 2 clinical program for OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin‑associated serine protease-2 (MASP-2), the key regulator of the lectin pathway of the immune system.
Galectin-3 sounds like a planet out of "Star Trek," but it can be much more ominous. Recently, distinguished integrative physician Isaac Eliaz, M.D., presented breakthrough research demonstrating that the protein Galectin-3 is an active biomarker for numerous life-threatening diseases. Even more importantly, Dr. Eliaz showed how Modified Citrus Pectin (MCP) binds and blocks Galectin-3 throughout the body.
› Verified 3 days ago
Mrs. Ava Greer Marshall-garza, PMHNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2190 N Grace Blvd, Chandler, AZ 85225 Phone: 480-955-0937 | |
Justin Cooper, PHYSICIAN ASSISTANT Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 333 N Dobson Rd Ste 15, Chandler, AZ 85224 Phone: 480-282-8336 | |
Rebecca L Rodgers, RNFA Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 500 N 56th St, Ste 5, Chandler, AZ 85226 Phone: 480-704-5080 Fax: 480-706-5247 | |
Nicole Charlotte Salvatore, PA-C Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-728-3000 |